Unknown

Dataset Information

Effect of vitamin D3 supplementation on cardiometabolic disease risk among overweight/obese adult males in the UK: A pilot randomised controlled trial.


ABSTRACT:

Background

Observational studies suggest links between reduced serum 25(OH)D concentration and increased cardiometabolic disease risk. However, these studies provide limited evidence of causation, with few conclusive randomised controlled trials (RCT) having been carried out to date. This RCT investigated the effect of vitamin D3 supplementation on vascular function and cardiometabolic disease risk markers, in 55 healthy males aged 18-65 years with plasma 25(OH)D concentration <75 mol L-1 and body mass index ≥24.9 kg m-2 .

Methods

Participants were assigned to consume 125 µg day-1 (5000 IU day-1 ) vitamin D3 or placebo for 8 weeks. Blood samples and vascular function measures were obtained at baseline, as well

SUBMITTER: Agbalalah T 

PROVIDER: S-EPMC10084017 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature